Par Pharmaceutical Targets US Injectables Market with JHP Pharmaceuticals Purchase
By Heather Cartwright
Pharma Deals Review: Vol 2014 Issue 2 (Table of Contents)
Published: 15 Feb-2014
DOI: 10.3833/pdr.v2014.i2.2009 ISSN: 1756-7874
Section: Mergers & Acquisitions
Fulltext:
Abstract
TPG’s Par Pharmaceutical has agreed to acquire JHP Pharmaceuticals for US$490 M in cash in order to add branded and generic sterile injectables to its product offering...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018